David Friedland
David Friedland publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Cancer therapeutics and mechanisms.
- World rank
- #1,575,941 of 7,710,434 ranked researchers
- Rank in United States
- #491,125 of 1,627,098
- Works
- 75
- Citations
- 2.1k
- Citations per work
- 28.6
What does David Friedland research?
David Friedland's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (17%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3748.7%
- Medicine3748.7%
- Everything else2534.0%
- Life Sciences1317.3%
- 1Pulmonary and Respiratory Medicine22% of their works
- 2Oncology17% of their works
- 3Molecular Biology13% of their works
- 4Surgery6% of their works
- 5Epidemiology4% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe David Friedland's research?
The keywords of their largest research topics: Clinical Trials, Chemotherapy, Targeted Therapy, Genomic Profiling, Biomarkers, Immunotherapy, ALK Inhibitors and EGFR Mutations.
- Staphylococcus aureus
- MRSA
- Prostate Cancer
- Topoisomerases
- KRAS Mutations
- DNA
- Taxanes
- EGFR Mutations
- Immunotherapy
- Genomic Profiling
- Chemotherapy
- Clinical Trials
- Targeted Therapy
- Biomarkers
- ALK Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- Cetuximab
- Genomic Profiles
- Small-Cell Lung Cancer
- Androgen Receptor
- Drug Delivery
- Nanocarriers
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Clinical Trials303 topics
- Chemotherapy273 topics
- Targeted Therapy222 topics
- Genomic Profiling212 topics
- Biomarkers172 topics
- Immunotherapy172 topics
- ALK Inhibitors131 topic
- EGFR Mutations131 topic
- Chemotherapy-Induced Peripheral Neuropathy111 topic
- Taxanes111 topic
- Cetuximab91 topic
- DNA91 topic
- Genomic Profiles91 topic
- KRAS Mutations91 topic
- Small-Cell Lung Cancer91 topic
- Topoisomerases91 topic
- Androgen Receptor81 topic
- Prostate Cancer81 topic
- Drug Delivery61 topic
- MRSA61 topic
- Nanocarriers61 topic
- Staphylococcus aureus61 topic
Where does David Friedland work?
David Friedland's main affiliation in the publication record is University of Pittsburgh, United States.
How many publications and citations does David Friedland have?
OpenAlex counts 75 works and 2,143 citations for David Friedland, an h-index of 23, ranking #1,575,941 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David Friedland. Posts are plain text and can be reported.